The IL‐1β pathway facilitates the transfer of lipids from lung‐resident mesenchymal cells to NK cells. Inhibiting the IL‐1β pathway can help alleviate lipid metabolism disorders in NK cells within the TME. This evidence concerns the gene IL1B and Disorder of lipid metabolism.